India could get its anti-covid vaccine for Children by September this year. Dr. Randeep Guleria, Director of AIIMS said.
Spoke to the India Today group, Mr. Guleria said, ” After the completion of the second and third phase of trials of Covaxin for children, the trial data would be made available by September and the vaccine itself is likely to be approved in the same month”.
The director also added that if Pfuzer-BioNTech’s vaccine gets a green signal in India then that could also be an option for children.
On May 12, the Drugs Controller General of India had granted permission to Bharat Biotech to carry out phase 2, phase 3 trials of Covaxin on children as young as two.
It’s to be noted that, Delhi AIIMS has already started screening children for these trials on June 7 that includes children between the age of 2-17.
Earlier, he had warned that India could get hit by a third COVID-19 wave in the next six to eight weeks if appropriate protocols are not followed.
However, Dr. Guleria disagreed that children will be particularly impacted by a potential third wave, saying there is “no reason to believe this theory.” Recently, a study undertaken by AIIMS-World Health Organization (WHO) found high sero-positivity among children. The initial findings indicate that the third wave “may not hit children disproportionately.”
